FDA cleared the BAROguard Donor Lung Preservation System from Paragonix Technologies, Inc. on Jan 30, 2026 under K254305, a special 510(k). The device falls under product code KDN, System, Perfusion, Kidney, regulated at 21 CFR 876.5880 as a Class 2 device. The review panel was Gastroenterology, Urology.
FDA logged the submission as received on Dec 31, 2025. The decision came 30 days later, inside the 90 FDA-day goal for a 510(k).
This is the only decision on file for Paragonix Technologies, Inc. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K254305?
K254305 is the FDA 510(k) for BAROguard Donor Lung Preservation System, submitted by Paragonix Technologies, Inc.. FDA's decision date was Jan 30, 2026, under product code KDN (System, Perfusion, Kidney).
Who makes the BAROguard Donor Lung Preservation System?
Paragonix Technologies, Inc., based in Waltham, MA, is the applicant of record for K254305.
How long did the K254305 review take?
FDA received the submission on Dec 31, 2025 and issued its decision on Jan 30, 2026, 30 days later.